123 related articles for article (PubMed ID: 30033839)
1. Prognostic value of pre-therapy C-reactive protein level in diffuse large B-cell lymphoma: a meta-analysis.
Qin W; Yuan Q; Wu J; Yu H; Wang Y; Chen Q
Leuk Lymphoma; 2019 Feb; 60(2):358-366. PubMed ID: 30033839
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma.
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):671-9. PubMed ID: 26361646
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.
Wang J; Zhou X; Liu Y; Li Z; Li X
PLoS One; 2017; 12(4):e0176008. PubMed ID: 28441396
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of baseline C-reactive protein in diffuse large B-cell lymphoma: a systematic review and meta-analysis.
Huang Z; Wang K; Huang S; Lu Q
Transl Cancer Res; 2023 Aug; 12(8):2169-2180. PubMed ID: 37701105
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.
Lu TX; Wu S; Cai DY; Hong TT; Zhang Y; Gao HQ; Hua HY; Wu XH
BMC Cancer; 2019 Jun; 19(1):553. PubMed ID: 31176361
[TBL] [Abstract][Full Text] [Related]
7. Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis.
Luan C; Wang F; Wei N; Chen B
Cancer Cell Int; 2020; 20():455. PubMed ID: 32973400
[TBL] [Abstract][Full Text] [Related]
8. Serum C-reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma.
Cao Y; Shi YX; Chen JO; Tan YT; Cai YC; Luo HY; Qiu MZ; Cai XY; Jin Y; Sun YL; Jiang WQ
Tumour Biol; 2012 Aug; 33(4):1039-44. PubMed ID: 22328138
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis.
Guo B; Tan X; Ke Q; Cen H
PLoS One; 2019; 14(1):e0210224. PubMed ID: 30625203
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of red blood cell distribution width and D-Dimer in diffuse large B-cell lymphoma: Systematic review and meta-analysis.
Rahchamani M; Sedghi M; Hakimi A; Nejatianfar M; Javaheri T; Tavakoli R; Ahmadi R; Makarem M; Azmi-Naei N; Zahmatkesh Sangani S; Kamandi N; Soleimanian A; Shavaleh R; Foogerdi M; Rahmani K
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1936. PubMed ID: 37997648
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of platelet-to-lymphocyte ratio on diffuse large B-cell lymphoma: a meta-analysis.
Chen Y; Zhang Z; Fang Q; Jian H
Cancer Cell Int; 2019; 19():245. PubMed ID: 31572062
[TBL] [Abstract][Full Text] [Related]
12. The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.
Han CL; Meng GX; Ding ZN; Dong ZR; Chen ZQ; Hong JG; Yan LJ; Liu H; Tian BW; Yang LS; Xue JS; Li T
Front Immunol; 2022; 13():827788. PubMed ID: 35211122
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
Gao N; Yang RN; Meng Z; Wang WH
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
[TBL] [Abstract][Full Text] [Related]
14. Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.
Niu JY; Tian T; Zhu HY; Liang JH; Wu W; Cao L; Lu RN; Wang L; Li JY; Xu W
Ann Hematol; 2018 Oct; 97(10):1841-1849. PubMed ID: 29860562
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: a meta-analysis.
Yan C; Xie Y; Hua Y; Li S; Fu H; Cheng Z; Wu J
Clin Transl Oncol; 2024 Feb; 26(2):515-523. PubMed ID: 37438653
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of C-reactive protein levels in patients with bone neoplasms: A meta-analysis.
Li W; Luo X; Liu Z; Chen Y; Li Z
PLoS One; 2018; 13(4):e0195769. PubMed ID: 29668751
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma: A Meta-Analysis.
Zhang Y; Wang J; Sui X; Li Y; Lu K; Fang X; Jiang Y; Wang X
Medicine (Baltimore); 2015 Sep; 94(36):e1432. PubMed ID: 26356696
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of C-Reactive Protein to Albumin Ratio in Gastric Cancer: A Meta-Analysis.
Yue L; Lu Y; Li Y; Wang Y
Nutr Cancer; 2021; 73(10):1864-1871. PubMed ID: 32940549
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pretreatment plasma D-dimer levels in patients with diffuse large B cell lymphoma (DLBCL).
Liu B; Li B; Zhou P; Yue W; Wang T; Wang J; Hu X; Zhang W; Chen J; Chen L; Gao L; He M; Yang J
Clin Chim Acta; 2018 Jul; 482():191-198. PubMed ID: 29649456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]